J1610 HCPCS Level II code: Injection, glucagon hydrochloride, per 1 mg
J1610 is the HCPCS code for “Injection, glucagon hydrochloride, per 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1610Injection, glucagon hydrochloride, per 1 mg
Short description: Glucagon hydrochloride/1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J1610 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1986
Where J1610 sits
- 1J codesDrugs administered other than orally
- 2Active code J1610Injection, glucagon hydrochloride, per 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1610 mean?
J1610 is the HCPCS code for “Injection, glucagon hydrochloride, per 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1610?
CMS lists J1610’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1610
All J codesJ1596Injection, glycopyrrolate, 0.1 mgJ1597Injection, glycopyrrolate (glyrx-pf), 0.1 mgJ1598Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mgJ1599Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mgJ1600Injection, gold sodium thiomalate, up to 50 mgJ1602Injection, golimumab, 1 mg, for intravenous useJ1611Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mgJ1612Injection, glucagon (gvoke), 0.01 mgJ1620Injection, gonadorelin hydrochloride, per 100 mcgJ1626Injection, granisetron hydrochloride, 100 mcgJ1627Injection, granisetron, extended-release, 0.1 mgJ1628Injection, guselkumab, 1 mg